Treatment for anxiety and depression associated with improved heart disease outcomes

Treating anxiety and depression reduced emergency room visits and rehospitalizations among people with heart disease, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

Merck unveils €290m biosafety testing facility in Maryland, US

Merck’s new €290m biosafety testing facility in Rockville features advanced testing capabilities. Credit: Merck/Business Wire. Germany-based Merck KGaA has announced the launch of a new

October 10, 2024

Year End results as of December 31, 2023 – Biotech Investments

Vitruvia Medical AG / Key word(s): Annual Results/Annual Report Vitruvia Medical AG: Year End results as of December 31, 2023 01-May-2024 / 08:36 CET/CEST Disclosure

May 2, 2024

Machine learning unlocks personalized approach to early ovarian cancer detection

For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians.

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.